In February 1994, the directors of major United Nations agencies, the Prime Minister of Bangladesh, medical researchers, international health advocates and politicians gathered in Dacca, Bangladesh, to celebrate the twenty-fifth anniversary of a life-saving technique known as oral rehydration therapy (ORT). UNICEF and the International Centre for Diarrhoeal Disease Research organized the meeting in order to recognize those who originally developed and promoted the therapy and to refocus attention on the continued underutilization of ORT throughout the world. ' More than two decades earlier, in Dacca, East Pakistan, and Calcutta, India, many of the people who attended the meeting, along with others, had developed the use of an extraordinarily simple solution consisting of sugar, salts, and water to save the lives of severely dehydrated adults, children, and infants.2 These researchers, some of whom had not yet completed their medical residencies, were affiliated with powerful U.S. institutions including Johns Hopkins, Harvard, the Centers for Disease Control, the U.S. Navy, and the National Institutes for Health. In 1962 they began work on effective therapies for cholera-induced diarrhoea which was claiming thousands of lives globally during seasonal epidemics. Within six years, these men produced and synthesized physiological evidence tha4t overturned the medical establishment's paradigm for diarrhoeal treatment. Through
The sight and plight of patients in this condition encouraged researchers to find better ways of treating diarrhoeal dehydration, but despite extensive experimentation, it was not until the mid 1920s that a relatively effective and safe treatment emerged. This entailed rehydration with expensive hospital-administered intravenous solutions. Although efficacious, it was essentially unavailable to the people most plagued by diarrhoea, those in the developing world.
The prevalence of cholera in the developing world inspired many scientists to search for a therapy that could be utilized in the field, far away from hospitals and the technologically advanced intravenous treatment. William B. Greenough III, a physician who was intimately involved with the study of cholera and worked for several years in Dacca, has pointed out that intravenous treatment was totally inadequate for cholera cases in the field: "I've been in the field with five thousand cases of cholera when the only thing you could do was ... drag people who were infected into the middle of the field so that they would not infect everyone else. So it was obvious that without some breakthrough ... you were not going to make a dent in cholera."'2
THE SEARCH FOR AN EFFECTIVE TREATMENT
In western medicine most scientific research on diarrhoea during the first half of the twentieth century can be divided into two categories. There were those researchers who studied the various aetiologies of diarrhoea and conceived of antibiotic treatments as a cure. They often subordinated practical issues of dehydration treatment and concentrated their efforts on the pathogen because they believed that the most effective therapies for diarrhoeal diseases could be found only when the causes were known.'3 Other researchers concentrated on finding a solution that could consistently rehydrate children without complications. Some of these people favoured various isotonic electrolyte solutions for diarrhoeal treatment. This categorization, however, should not suggest that there were two separate groups; in fact, many researchers concerned themselves with all aspects of diarrhoeal disease.
Those who searched for a universal cure for diarrhoea often advocated solutions concocted from carob flour, bananas, or other substances. In 1950, Per Selander, a Swedish doctor, championed the use of carrot soup at a time when some American doctors were publicizing the attributes of carob flour and dehydrated bananas. '4 According to Selander, "Carrot soup is an extremely reliable, easily obtainable, and simple, nourishing substance 
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The historv of oral rehvdration therapy which acts promptly in the treatment of acute diarrhoeal disturbances in infants. In my own experience, I have found carrot soup to be far superior to all substances hitherto employed."'5 Regardless of effectiveness, diarrhoeal treatments like Selander's reflected the lack of information doctors then had about the physiological mechanisms of diarrhoea. The developers of these treatments therefore gauged their success on a case-by-case basis: how many patients improved and how quickly. They did not explain why, they improved.
Nevertheless, these eccentric therapies often produced outwardly impressive results while utilizing methodologies now considered archaic. In a 1950 study that used dehydrated banana, the average time of complete recovery from dehydration in infants who received the treatment was 2.9 days, in sharp contrast to 5.02 days for the control group receiving routine hospital therapy.'6 Fruit and vegetable therapies were always oral, whereas most others remained intravenous. Doctors found that intravenous solutions worked well and provided them with precise control over the treatment, while oral solutions appeared scientifically unsound.
The composition of intravenous solutions changed with increased metabolic research during the 1940s and 1950s, yet, despite this, the basic treatment protocol remained the same. The therapy involved the parenteral administration of electrolyte solutions, blood transfusions, fasting, and the gradual commencement of feeding at the end of the "starvation" period. 1 This fasting was a crucial element of most diarrhoeal therapies and was based on the pervasive beliefs that the gastrointestinal tract required an opportunity to rest and recover and that oral intake aggravated diarrhoea since the diarrhoeic gut could not absorb fluids.'8 With therapies of this sort, infants often needed to stay in hospital for one to two weeks in order to recover.'9 These lengthy stays can partly be attributed to the malnourishing effect of the treatments on the patients. Even with these therapies, public health physicians worried about infant diarrhoeal epidemics in nurseries which "frequently develop[edl a high case fatality rate with attendant unfavorable publicity".2(0 These high death rates highlight the overall ineffectiveness of the treatments then available; diarrhoea still posed a major public health threat to young children.
DANIEL DARROW AND THE COMPOSITION OF DIARRHOEA
At the heart of ineffective diarrhoeal therapies was a lack of knowledge about the electrolytes expelled and how best to replenish them. During the 1 940s Dr Daniel Darrow of Yale University began ground-breaking electrolyte studies that reverberated through the scientific community; at the same time much work was being done on the physical processes in the body that diarrhoea interrupts and alters.2' Darrow began advocating rehydration solutions that included potassium, sodium chloride, and glucose based on s Per Selander, 'Carrot soup in the treatmnent of infantile diarrhea', J. Pedaitr., 1950, 36 Scientists involved in the discovery of ORT disagree on the importance of his contribution. Greenough believes that Darrow developed good rational therapeutic solutions, especially one which could be parenterally administered. Although it was important that Darrow drew scientific attention to the repair of electrolyte deficits in children, Greenough asserts that "he did not have any of the information which allowed them [oral solutions] to take off after 1967 Darrow's work seemed all the more significant since children were particularly at risk from debilitating or fatal dehydration due to the lack of physiological knowledge and its reflection in various products. For example, infant formulas and over-the-counter oral rehydration solutions contained far too much sugar and salt, a potentially lethal combination which aggravated diarrhoea.28 When a person ingests a solution with a higher concentration of sugar or salt than the body, water osmotically leaves the body and enters the intestinal lumen (in an attempt to maintain isotonicity), and this results in dehydration as well as higher salt concentrations in the body.29 Concentrated sugar and salt solutions employed in the 1 950s were born of a lack of knowledge of certain biological mechanisms 22 Daniel Darrow, et at., ' absorption.35 Riklis and Quastel inspired another sugar physiologist, Robert Crane, to define the mechanism for the active transport of glucose in the presence of sodium.36 All these studies ultimately helped in the understanding, if not the development, of ORT since they illustrated the coupling of glucose and sodium, the therapy's major constituents. This type of research would later be relevant when the effective and relatively safe concentrations of modern oral therapy were being determined.37 Most acute watery diarrhoeal diseases, such as cholera, do not destroy the mucosal membrane of the small intestine, although they may alter it.38 While diarrhoea results from an increase in the net fluid output from the intestine which in turn leads to dehydration, the absorption of fluid may continue-the problem lies with the net output. One could try to rehydrate by drinking lots of water, but would still lose water and expel much more salt. This is where ORT and the glucose and sodium chloride mechanism are relevant. When glucose is added to the mucosal membrane (where it is absorbed by the sites R. B. Fisher proposed), sodium chloride intake is greatly increased along with glucose and water. Even if the person continues to expel considerable amounts of fluid, the glucose allows the absorption of more fluid than is being expelled. Diarrhoea may continue, but the dehydration will be corrected.39
With the close of the 1950s, a new force in physiology emerged at the Harvard Biophysics laboratory. There, Drs Curran, Zalusky and Schultz furthered the work of earlier physiologists and concentrated on links between sugar and salt absorption.4" Dr Michael Field, who worked in the laboratory during the time of Schultz, Curran, and Zalusky, contends that their work "showed two things: one is that sodium dependence of sugar absorption really means that sugar and sodium are absorbed together, that is that their movement is coupled on a particular transport protein ... and then they showed it also to be true for amino acids".4' It was the sugar and sodium co-transport mechanism which Schultz and Curran elegantly documented that was the cornerstone of their work.42
Schultz and Curran's work had broad implications for electrolyte physiologists. When Darrow put glucose in his rehydration solutions during the late 1940s, he did so in part because he thought that it contributed calories to the patient's system. Schultz and Curran demonstrated that the function of glucose in solution was "entirely independent of " E. Riklis Regardless of the influences, Phillips' work first demonstrated that oral therapy could be viable. Today, most ORT researchers praise Phillips for his finding. They believe that it was doubly important since it furthered studies carried out only in animal models, and it contradicted the conventional wisdom of the time which required that the gut be starved in all diarrhoeal treatment. Phillips had shown that cholera patients might be able to drink their therapy. This was the first discovery of a rational scientifically-based oral therapy for cholera patients.
Spurred on by this success, Phillips excitedly extrapolated his observation to a clinical trial. On 4 August 1962, his team in Manila, led by Wallace, treated three patients with a potent oral electrolyte solution containing high concentrations of glucose and sodium and achieved good results. Phillips then instructed Wallace to set up a large clinical trial for this solution, to be carried out in September when Phillips would be away. Of the thirty patients involved in the study, five died.5" Since the oral solutions were three times isotonic concentration, and intravenous fluids were co-administered, fluid overload resulted and this led to congestive heart failure.5' Their deaths may also have occurred because, as one researcher maintains, the clinical trial was carried out under conditions which were inferior to a standard trial since "Phillips wanted a method to approximate actual physical facilities then present in much of the world".52 Phillips did not prescribe standard patient monitoring because he wanted even a young child to be able to carry out the treatment.53 Given the nature of a potential panacea for diarrhoea, he recognized that it would have to be utilizable under terrible conditions; his experiment attempted to replicate these and confirm the treatment. Perhaps Phillips believed that he was on the verge of discovering a magic bullet for dehydration caused by cholera. Accordingly, he held a press conference before sending Wallace off to carry out the clinical trial. He reportedly stated that he and his colleagues were on the verge of discovering an oral cure for cholera.54 This public optimism probably made the failure immensely more painful. The 
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The historv of oral rehvdration therapy weakened not only by his search for a magic bullet, but also by a faulty scientific hypothesis. According tQ Hirschhorn, Phillips and his colleagues worked on the premise that the intestinal sodium pump had been poisoned by cholera.55 The purpose of the so-called "cholera cocktail" was therefore to "unpoison the pump".56
The deaths that resulted had major repercussions for Phillips and his colleagues. According to a visitor at the Naval Research Center in the Philippines during the autumn of 1962, soon after the tragedy, Wallace "felt badly about it", and Phillips "felt so badly about it he didn't pursue it any further".57 These emotions even led Phillips to conceal the deaths and to delay publishing the other results, including his distinguished verification of glucose-sodium absorption in vivo, until 1964.
Phillips Joshua NalibowF Ruxini Thus, although the mode of practical implementation of a glucose-sodium solution had been an overall failure, even Phillips recognized that his work outlined the possibility for an effective therapy. While he saw the potential for oral therapy, he could not and would not overcome his shock from the Philippines. In the four ensuing years oral therapy research was significantly slowed down and even threatened by Phillips' trauma.
DIARRHOEAL TREATMENT IN THE EARLY 1960s
By the mid-1960s, Phillips was not the only supporter of careful balance studies with fluid therapies. Other doctors were acutely aware that fluid therapy, if improperly administered, could do more harm than good. An article published in 1964 mentioned that incorrectly administered therapy could result in death.63 In spite of this danger, the authors proceeded to state that children could be given oral therapy to supplement intravenous therapy and eventually work their way into oral maintenance therapy without intravenous solution. Consequently, it appears that doctors continued to view oral therapy as the transition between parenteral therapy and feeding for which Darrow had designed it. Two other U.S. physicians that year wrote that "There can never be an exact answer to this question [of glucose-salt proportionsi for the particular patient to be treated, nor is there any laboratory test that can be done easily and quickly enough to provide an answer to this question in a clinical situation".64 Therefore, despite their advocacy of a therapy consisting of sodium chloride and glucose, they did not believe that there existed one ideal rehydration solution. Given the unique circumstances of each patient, there could be no specific formula. Clearly, the concept of oral rehydration was in the air, but its precise form evaded discovery. The historv of orail rehvdration therapy which cholera researchers operated at the time. On the one hand, they "recognized that intravenous hydration was not a solution to the problems in the field 'cause it was too restrictive and expensive to use in the situation where cholera occurred" and therefore worked toward a non-intravenous therapy. On the other hand, most researchers readily admit that even the concept of an oral therapy through the late 1960s "was quite unbelievable to most people".67
When Greenough arrived at the laboratory, untreated villagers with cholera had a 30 to 40 per cent mortality rate. As at that time the only cholera treatment considered acceptable was intravenous therapy, the researchers at the laboratory were developing ways to treat large numbers of people in the field with it.68 Given the morbid situation, Greenough and the others concentrated on improving the parenteral therapy and on finding ways to shorten the duration of the cholera. They therefore closely monitored the fluid intake and output of the patients and attempted to implement and modify Phillips' parenteral solution that had maintained such impressively low mortality rates in past cholera epidemics. Within one year Greenough and the staff had brought the mortality rate in the hospital down to under I per cent.6'9 With the cholera situation under control, the laboratory could then begin to expand its efforts and investigate the physiology of cholera and electrolyte transport in the gut. At that time, the leadership of the laboratory recruited Dr Hirschhom and others to go to Dacca.7" When Hirschhorn arrived, Greenough and his colleagues were studying the defects in the epithelial transport system that cholera impaired. Initially, Hirschhorn one litre of solution per hour regardless of output.88 The solution, therefore, was not meant as a practical therapy that could be introduced in the field, since the patients had tubes in their stomachs and intestinal tracts; the researchers set out to lay the groundwork for oral therapy.
The results of Hirschhom's study, carried out between November 1966 and March 1967, showed that a glucose solution always lowered the net stool output (indicating net absorption) and that a solution without glucose invariably increased it.89 Effectively, the study confirmed the work that Phillips had done in 1962 and published in 1964.9" The researchers cautiously concluded that "oral glucose therapy could be of value in the treatment of cholera and that the requirement for expensive and scarce intravenous fluids may be reduced thereby".9' They limited their conclusion to cholera since they could not imagine using such a treatment on other patients. People were dying from cholera in far off areas, where intravenous treatment could not be supplied, and they wanted a therapy for them. Although Hirschhorn recognized some of the practical applications that Sachar's work and the follow-up had suggested, he could not foresee its major implications.
At this point, however, there were physicians who saw the full potential of oral therapy. At a presentation of Hirschhom's findings in Dacca, one of the plantation doctors, Dr Mackay, responded ecstatically.
He [Dr Mackay] got up and said "This is one of the most profound developments in the treatment of . .. cholera diarrhoea this century". And I remember being a little startled by that and saying to myself . . "gosh, maybe he's right". But we had come at it [cholera] in terms of this [being] a really amazing scientific finding and it was based on true physiology .., we were also preparing ourselves for using it as an emergency measure when we ran out of IV fluids. We were not yet saying that this would be a great thing to put into a village. It seemed like this was something we could use as an emergency backup.92
Perhaps it is due to such experiences that Hirschhorn asserts that his balance studies, along with the work which demonstrated that cholera allowed co-transport to function, signified the point at which the physiological basis for oral therapy had been discovered. 93
Even after the successful study of decreased stool output, Hirschhorn remained pessimistic about the future of oral therapy research, partly because he paid meticulous attention to every indicator, and this intensive analysis made him question whether there would ever be a practical basis for oral therapy.94 Hirschhorn believed that he had X Norbert Hirschhorn, Joseph L. Kinzie, David B. Sachar, Robert S. Northrup, James 0. Taylor, S. Zafar Ahmad, and Robert A. Philips, 'Decrease in net stool output in cholera during intestinal perfusion with glucosecontaining solutions', N. Engl. J. Med., 25 July 1968, 176-81, on pp. 176-7. The title of this article and others related to this topic could deceive readers unfamiliar with the experimentation since they imply that the stool output decreased with intake of glucose-sodium solutions. In fact, the stool output might increase as more solution is ingested. The crucial point is that the net amount, the solution ingested subtracted by the stool plus any vomitus, was positive. Thus, although there may have been more fluid expelled from the body than before treatment, overall the intestines absorbed more than was lost. Calcutta; and they were both very important. I think that Nate's [Pierce's was a little more meticulous; he had a better set-up and the sense to do it, I don't think any particular additional credit derives to him for doing it first". framework and made an important contribution to the feasibility of an oral glucose solution. The conclusions reached by both groups were reinforced tremendously by their independently concordant results. Their work demonstrated that Phillips' observation had not been an anomaly and carried the promise for a practical oral rehydration therapy a great step ahead.'0'
With the scientific groundwork laid for ORT, one might expect that a practical therapy, or at least experiments on oral therapy would have followed immediately. On the contrary, oral rehydration-related work slowed because the researchers had to wait for the next cholera season. According to Henry Mosley, the chief epidemiologist in Dacca at the time, Phillips felt that the research questions had been answered and that therefore, the Dacca team's work with oral therapy had been completed.'02 Hirschhorn attributes Phillips' "change of heart" to the kinship bonds he felt for those doctors with whom he worked. After his experiment and a trip to the United States, Hirschhorn had intended to return to Dacca, but his visa was not approved.'03 Phillips, who had confidence in him, "didn't quite trust the next crew that came along", 104 and with Hirschhorn absent from the laboratory, much of the inspiration for progress toward an oral therapy faded.
THE REINS ARE PASSED
The crew that arrived in August 1967 consisted of Drs Richard Cash and David Nalin. At the time, Nalin, twenty-six years of age, had completed only the first year of his medical residency when the international research office at the National Institutes of Health assigned him to Dacca. Nalin was told only that he would be working on clinical research on cholera.'05 Cash, also twenty-six, had just finished his internship in surgery and had become a U.S. Public Health Service Officer. The National Institute for Allergies and Infectious Disease assigned him to Dacca. Neither doctor had had any previous experience with cholera or epidemic diarrhoea.'06
There was some continuity between the old guard at the laboratory and the new. Before arriving in Dacca, Nalin and Cash heard Hirschhorn and Pierce present their findings at a cholera symposium in Palo Alto, California, in July 1967. Hirschhorn's study came under the heading 'Pathophysiologic studies in man and in animals' rather than a title which which might have suggested a practical component of the work.'07 Nalin's and Cash's reactions were that the physiological work and the possibility for oral therapy were "interesting" but unfeasible.""' Nalin felt that there was "absolutely no one who believed that an oral therapy could work as a practical thing in rural areas or even in hospitals". In '' According to Sachar, the study with Hirschhorn was impractical because "We didn't develop that protocol as an optimal therapeutic regimen; it was just a metabolic study, to determine a yes-or-no phenomenon, to shift the patient from negative balance to positive balance. And the logical way to do that, when you're doing a metabolic study, as opposed to making up a treatment protocol, is to use a fixed dose", Sachar, interview, 29 '"' Generally, those patients who had no determinable pulse in their radial artery were considered to be in shock.
They generally required IV therapy equivalent to 10 per cent of body weight at the time of admission. Nalin, written comments, April 1994.
1'' This therapy cannot accurately be labelled oral rehydration therapy since IV therapy rehydrated the patients. The oral glucose solution maintained their hydration status and should therefore be referred to as oral mlaintena(nllce therapy.
_'x Islam, personal interview, 24 August 1993.
'2' Nal in's protocol called for 4.22 grams of NaCI, .5 grain of KCI, 4 grams of NaHCO , and 20 grams of glucose mixed in one litre of water. The WHO's official formula today is based on the formula used in Calcutta and consists of 3.5 grams NaCI, 1.5 grams KCI, 2.5 gramis NaHCO3, and 20 grams of glucose dissolved in one litre of water. Van Heyningen and Seal allocated two sentences to Nalin's revision and neglected to mention the breakthrough fromil orogastric tubes to oral administration. Thus the first practical ORT trial is poorly documented in their book-according to the text, no significant breakthrough was made in April 1968. Op .cit., note 6 above. pp. 237-8. containing glucose and electrolytes can eliminate the need for over three-quarters of the intravenous-fluid requirement in the therapy of acute cholera in adults". However, they stopped short of advocating their therapy in all situations, claiming that although "mild cases of cholera [without shock] may be treated with oral solution alone", "specially trained staff' were still needed to oversee patients being treated with oral therapy.'30 Oral therapy worked, but it had only been proved effective in a meticulously controlled and monitored environment; the next step was to demonstrate its usefulness in the rural areas of East Pakistan where intravenous therapy was unavailable.
While oral therapy research moved forward, its proven utility caused the previously fairly subtle competition between the Dacca and Calcutta cholera laboratories to surface. After finishing the report for the second protocol, Nalin travelled to the Johns Hopkins research laboratory in Calcutta to share notes.'3' Although the John Hopkins staff had advanced Hirschhorn's work a year earlier, they had not made the same progress as Nalin and Cash.'32 Nalin claims "they greeted my news [of the second protocol] initially very hostilely and said it was reckless and irresponsible and would never be practical".'33 Nalin does not attribute their reaction to jealousies or indifference, rather, he believes that the group in Calcutta was familiar with Phillips' failure and had been influenced by the "folklore" surrounding cholera. For example, since vomiting was a characteristic of the first few hours of the disease, these researchers could not imagine patients swallowing and holding down so much fluid.'34 One month after Nalin's visit, Cash visited Calcutta and found the group carrying out an oral therapy protocol that utilized nasogastric tubing and tested the efficacy of a glucose-electrolyte solution. Then, at a conference in Teheran in August, Pierce approached Nalin and Cash and asked them whether they would be interested in co-publishing their results; Nalin replied that the results had already been published in the Lancet, and Pierce expressed disappointment. ' '-" Van Heyningen and Seal present Carpenter's ambiguous version of the story. They state that when Pierce took over the laboratory in 1966, he began testing oral glucose-electrolyte solution, which leads the reader to believe that there was an oral therapy in 1966 and that it was first developed in Calcutta. This recapitulation of the story conveys a misunderstanding about the meaning of oral rehydration. For example, van Heyningen and Seal call the replication by Calcutta of Hirschhorn's work oral rehydration when, in fact, it was a metabolic study which did not constitute a practical therapy. Op. cit., note 6 above, pp. 236, 240.
14' Pierce, personal correspondence, 20 April 1994, and personal interview (recorded), 31 March 1992. It is crucial to recognize that the study by Pierce had been planned between September 1967 and March 1968-before Nalin's visit and possibly before Nalin wrote the second protocol. However, the study as planned and conducted still used nasogastric tubes-it was not precisely a practical oral therapy. This supports the assertion by Pierce that Nalin only encouraged Calcutta to switch to a glucose-based oral therapy study. Pierce does not believe that "it INalin's visit] affected the design of the trial we carried out" (emphasis mine). Furthermore, Pierce recalls that, by Nalin's arrival, the maltose study already appeared inferior to IV therapy. He In the autumn of 1968, Nalin and Cash wrote an oral rehydration therapy protocol to be carried out in the field, in Matlab Bazaar, rural East Pakistan. They aimed to carry out the trial not only to prove the effectiveness of their therapy, but also to best treat the epidemic in Matlab. In Matlab there would be a limited supply of intravenous solutions and there would be patients who, without oral rehydration therapy, might have no treatment whatsoever. Phillips responded negatively to their proposal and told them that they would not be permitted to execute it. Given the impending situation in Matlab, Nalin and Cash felt that they were encountering "irrational fears". Moreover, no one had given them a full account of the circumstances surrounding the five deaths in the Philippines, a lack of communication which certainly increased the mysteriousness of Phillips' negativity.
Finding Phillips to be totally intractable and having heard of a telegram from the National Institutes of Health that research should not continue, Nalin, Cash, and their supporters at the laboratory began discussing alternatives. One option was to ignore their orders and proceed with the study. However, they swiftly concluded that as Public Health Service Officers, they could thereby be subject to court martial.'47 With this punishment and Phillips' attitude in mind, Nalin and Cash turned to Henry Mosley, the head of epidemiology at the Cholera Re.search Laboratory, for help.
Due to a previous arrangement, Mosley functioned autonomously at the Cholera Research Laboratory, and only had to obtain project approval from the Centers for Disease Control (CDC) and his superior at the Epidemiological Intelligence Service, Alex Langmuir.'48 Mosley told Phillips that he wanted Nalin's and Cash's Matlab protocol performed. Mosley asserts that Phillips had no problems with the plan, provided that Nalin and Cash did not work on the project full time, and that his only reservation about the project initially had been that he did not want his clinical researchers working on practical field trials instead of research. Mosley wanted Nalin and Cash to play a major role in the trial since "they had been involved intimately with the development of the protocol ... and they were the ones that would be most capable of managing the project".'49 Mosley therefore resolved initially to have two Epidemiological Intelligence Service officers sent to Dacca through the CDC. These doctors, under the direction of Nalin and Cash, would carry out the protocol in Matlab. Langmuir readily agreed to the plan, and Phillips expressed no further objection. The support Langmuir provided was crucial to the 146 Ibid. 14' Nalin, interview, 14 February 1992, transcript p. 13, and personal correspondence, 26 March 1992. 14' Ibid., pp. 6, 7.
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The historv of oral rehxdration therapy implementation of the protocol, as Mosley explains, he "saw the world-wide impact of this, but the rest of us still didn't quite appreciate it. 150 Langmuir, who communicated with Phillips frequently, says that he never comprehended just why Phillips did not desire to go ahead with the field trial. He corroborates Mosley's assertion that Phillips distinguished between the "applied research", which Nalin and Cash desired, and "basic fundamental research", which Phillips wanted them to do.'5' Langmuir, however, believes that there might have been more to Phillips' resistance than this distinction:
Part of this [resistance to the Matlab trial] also was a divided loyalty ... in Dr Phillips himself because he was the former chief of the lab in Taiwan (NAMRU-2), and they were working on this also. After all, they had been working on it first, before anything was even discussed in Dacca... and a divided interest is just not the way. He had a definite continuing loyalty to the work that was being done in Taiwan... and [believed] they should have the opportunity to do the field test.'52
Langmuir states that Phillips approved the trial, or "at least he didn't stop it".'553 Both Mosley and Langmuir agree that although Phillips did not want the trial to go ahead in Dacca, he did not totally impede the process. Nevertheless, Nalin believes that there was something more to this resistance. He asserts that Phillips had an agreement with John Seal at the National Institutes for Health, and, at least initially, attempted to block the process. This interpretation of the situation is not inconsistent with the views of Langmuir and Mosley; however, they feel that Nalin has exaggerated Phillips' response. 154 The involvement of Seal probably increased Nalin's perception of a threatening atmosphere. According to Nalin and others, Seal sent a menacing telegram in which he backed up Phillips (and was apparently inspired by previous communication with Phillips). 55 This telegram has never been found. Seal claimed that he "cannot recollect such a cable, doubts that he would have used their [threatening] wording" and could not find it in any of his files.'56 However, there is evidence of correspondence between Seal and Phillips on this very issue.
On 11 October 1968, Seal, in his capacity as Chairman of the NIH Cholera Advisory Committee, wrote a letter to Phillips which indicated ongoing discussion on the topic of the Matlab trial. By this time, Seal wrote, the request for health officers from Langmuir had already been filed, and Seal expressed some reservations about this after having read the article by Nalin and others on 'Oral maintenance therapy for cholera in adults' published in the Lancet. Seal responded very apprehensively to a cautionary sentence in the report which read, "We would emphasize that the continued need for intravenous therapy and for careful records of intake and output dictate that specially trained staff must 152 Ibid.
-5-3 Ibid.
-54 Ibid., p. 4, and Mosley, interview, 25 February 1992, transcript p. 9.
-5 Cash, op. cit., note 39 above, p. 12.
5' Van Heyningen and Seal, op. cit., note 6 above p. 238.
supervise the management of cholera patients who are on oral maintenance therapy". Seal concluded from this judicious comment that the Matlab trial should be placed on the back burner and "be reviewed in depth within the laboratory and by the Technical and Clinical Research Committees before decision". 157 Seal desired to block the Matlab field study for at least a few months.
In conclusion Seal wrote, "It was evident during your [Phillips'] visit that I had misinterpreted your problem in the earlier letter and now I find myself not knowing whether you are or are not in favor of the oral therapy trial".'58 Apparently, Phillips had conveyed some reservations about the project to Seal, but recent developments had rendered Phillips' opinion ambiguous. Seal therefore intimated that Phillips should convey what he wanted done with the study so that Seal could rubber stamp it. Whether or not Seal sent a menacing telegram, he evidently wanted the process halted for the time being,'59 and although his words were not threatening, they were communicated in an official capacity. Furthermore, had the study gone to committee the epidemic would have passed and the opportunity to carry it out would have been delayed until the following cholera season, by which time Nalin would have returned to the United States. His term at the laboratory had not been renewed. All the objections and insinuated threats which Phillips made to Cash and Nalin exhilarated and encouraged them to move ahead. In Nalin's words, "it showed us that there was a stick somewhere behind the carrot". 161 Cash and Nalin, with their Bengali and U.S. colleagues, chased and reached the carrot at Matlab through the support of Langmuir and Mosley. Their study confirmed that some cholera patients could be rehydrated with oral rehydration therapy alone and that field staff could be trained to administer the therapy with ease.'6' Most significant was their proof that oral rehydration therapy was a practical treatment which could be used to treat large numbers of patients in primitive conditions where little intravenous therapy was available.
With the Matlab study complete, ORT had one scientifically supported use: treatment for adult cholera patients. A host of researchers at the laboratory and in Calcutta recognized, however, that the potential extended far beyond cholera in adults. Nalin, Cash, and their colleagues, made the next significant breakthrough: they showed that oral rehydration solution is "as effective in the non-cholera diarrhoeal patients as in cholera "' John R. Seal, MD, personal letter to Robert A. Phillips, I I October 1968. Washington, DC.
1.58 Ibid. 15' This incident further discredits the history of ORT presented in Van Heyningen's and Seal's book. The preface is extremely telling and explains well why the nature of such controversies was not described. In van Heyningen's section of the preface he writes that he "is grateful, deeply grateful, to his present collaborator, J.R.S. IJohn R. Seal 1, who proposed the writing of this book in the first place, and without whose encyclopaedic and unfailing support not only would this book never have been written, but mnanv of the main events rec orded in it would not have happened." (Emphasis mine). These words highlight the dedication with which this book presents Seal in the most positive light. Nothing of a critical nature is mentioned, not even the potentially detrimental relationship between Seal and Phillips. Op. cit., note 6 above, preface.
'i'" Nalin, interview, 14 February 1992, transcript p. 14. 161 The historv of oral rehydration therapy patients".'62 In another study, Nalin and Cash and others showed that ORT alone may be used to treat moderate to severe dehydration.'63 Additionally, they demonstrated the effective use of ORT in the treatment of children.'64 GAINING MOMENTUM Perhaps the greatest practical ORT success after Matlab was the Calcutta team's work demonstrating that ORT could be implemented even under disastrous circumstances. Dilip Mahalanabis led the challenging work in refugee camps during the Bangladesh War of Independence.'65 Unlike the Matlab study, in which trained staff charted every patient, family members were responsible for the administration of the oral rehydration solution.'66 Thus the refugee camp work not only proved that ORT could be used in emergency situations, but it also saved lives that otherwise would have been lost. Moreover, the work enabled ORT to "really hit the map ... [since] it probably took that kind of a demonstration in a crisis to really document what could be done". 167 For those doctors such as Langmuir, who were involved with ORT on a political, behind-the-scenes level, Mahalanabis's work was crucial: "Cash and Nalin's work is tremendous, and I'm not denigrating that at all, but the Mahalanabis one turned me on".'68 This comment shows how the Mahalanabis study differed from that at Matlab where, although the conditions were terrible, the study was smaller and it was entirely premeditated. Mahalanabis's work was quite simply a response to an emergency and therefore drew the attention of global health organizations such as the United Nations Children's Fund and the World Health Organization.
ORT began demonstrating success after success as physicians experimented with it in different cases of diarrhoea and among patients of all ages. In 1971 and 1972, soon after the work by Mahalanabis, Hirschhorn returned to ORT research, this time in Arizona. Under the influence of Bob Gordon, who six years earlier had sent Sachar to the Dacca laboratory, Hirschhorn worked with Apache children who were suffering from diarrhoea of various aetiologies (although never cholera).
He found that the treatment then being used for diarrhoea was "old-fashioned" since it called for intravenous fluids while starving the gut.'69 Cash taught Hirschhorn how to use ORT, and they achieved excellent results by implementing early feeding along with the therapy. Among their findings, they demonstrated that children down to the age of one month could be treated with oral therapy. Most importantly, their study indicated that dehydrated children would drink the solution to the point of hydration-they instinctively knew how much they needed.'70 Within one year, Hirschhorn and others had confirmed their hunch that ad libitum oral therapy worked. '7' Hirschhorn remarks that this discovery clearly showed the superiority of ORT over intravenous treatment, where the chance for error while administering the solution was much greater because intake and output had to be carefully recorded.'72 ORT eliminated the necessity for that process since the patient would drink the proper amount.
ORT ENTERS THE U.S.
With his work in a Native American reservation, Hirschhorn brought ORT to the front locked doors of U.S. clinicians. Whereas the work in Dacca and Calcutta had involved cholera, an exotic affliction, Hirschhom treated the kind of diarrhoea that was familiar to American physicians. Moreover, in Dacca ORT had been utilized under primitive conditions, but in the U.S. Hirschhorn used it in a technologically more advanced environment. An editorial comment following his ad libitum study stated that "a similar approach should be evaluated in modern urban settings under equally carefully controlled conditions". 173 This illustrates the suspicion with which contemporary American medicine treated ORT, as well as the disbelief that a therapy so simple could out-perform high technology. One anecdote which Hirschhorn tells demonstrates this type of conservatism and arrogance, especially among paediatricians:
I had an anthropologist friend who adopted an Apache child from the reservation where we were working. He used to be the anthropologist on the reservation. And then he went to Arkansas to teach and the Apache child came down with severe diarrhoea and he called me up and he said desperately, "Look, my son's in the hospital and they're giving him all sorts of intravenous fluids. The diarrhoea's not stopping, he's losing weight, they're not feeding him. I know that you did this work in Arizona and it didn't look like that". And he said, "Would you call this professor of paediatrics and just collegiately talk to him'?" So I called up the professor and told him that in our experience with Apache children this is what we found and here's the publication and so on. And he said to me, "Doctor, doctor, our children are not the same as your children". He was treating an Apache child from the same reservation. 174
Clearly some doctors in the medical establishment viewed ORT as a solution for problems in the developing world, but not in the industrialized nations and, furthermore, they overlooked the substantial scientific evidence which supported its use. With the work of others set out to internationalize and expand the laboratory.'79 Greenough states that the major difficulties which it faced grew out of the lack of "any political commitment or any support, other than for scientific projects, to implement any of the knowledge that had been gained up to that point".'8" Despite the obstacles, ORT managed to achieve worldwide notoriety and acceptance in record time.
In Hirschhorn) , it was virtually a practical therapy. The scientific record contests this conclusion. Although their work made use of a solution similar in composition to Nalin's, they were carrying out metabolic studies. The instrumentation which they used was too bulky to be practical. Hirschhorn himself maintains that after his work in Dacca and his departure from the Cholera Research 17' Greenough, interview, 10 January 1992, transcript pp. 5-6.°I bid.
'8' 'Control of diarrhoeal diseases: WHO's programme takes shape', op. cit., note 7 above, p. 369. 1x2 Ibid., p. 372.
'13 The story of ORT after 1968 remains mostly unexplored, perhaps because many of the people most interested in it (and able to write about it) are engaged in a fierce battle for its acceptance. I attempted to piece together some of the politicking which succeeded the studies of Mahalanabis and Hirschhorn in the early 1 970s but found that it deserves an essay of its own.
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The historv of oral rehydration therapy Laboratory, he "was not optimistic that ORT was feasible as a routine treatment. That task was left to David Nalin and Richard Cash". 184 Hirschhom's comment evokes the image of a runner handing over the baton to another and implies that his work smoothly progressed to Nalin's and Cash's breakthrough. This view of the development of ORT-that it was a scientific progression-provides two frameworks for interpreting the discovery. The first examines it as the culmination of decades of research, while the second suggests that ORT may have been "discovered" soon after early glucose-sodium absorption research.
THE ROAD TO ORT
If the development of ORT were a simple progression, the treatment might have culminated from work begun as early as 1832 when Thomas Latta used a saline solution intravenously to treat cholera.'85 Despite some encouraging results, he did not further his research. His work may, however, be considered as the beginning of the intravenous therapy that Leonard Rogers advanced and Phillips virtually perfected in the late 1 950s. 186 Nevertheless, reconstructing the discovery of ORT over a century stretches the limits of definitively identifying a scientific progression.
While the 1 830s may seem too distant to establish linearity, the transport work completed in the 1950s seems to signify a point of departure, albeit a minor one, for findings that resulted in ORT in 1968. One could credibly argue than any one of the major physiological breakthroughs beginning with Darrow's denotes the start of the development of ORT. Although the discovery of ORT itself was not directly dependent on the physiological studies of the 1940s and 1950s, these, especially glucose-sodium co-transport theory, provided essential proof for the theoretical utility of ORT since, according to Hirschhom, "empirical findings were probably not enough to solidify a therapy".'87 In other words, even if someone had stumbled onto the correct mixture for oral therapy, it would not have been accepted without supportive physiological paradigms because so much evidence against oral therapy had accumulated.
Despite the appearance of a single progression in the development of ORT, in retrospect one can in fact differentiate two distinct lines of scientific work leading to the discovery.
The first, the development of co-transport theory, began with Crane, Riklis, and Quastel in the 1950s, and peaked with Schultz and Curran in the mid-1960s. The second, the execution of numerous metabolic studies, began with the serendipitous observations of Phillips in the Philippines. Sachar's work evolved from Phillips' poisoned sodium pump, and Hirschhorn executed his experiment because of Sachar's work and Phillips' study. These two physiological developments were confirmed in Phillips' work since he demonstrated that the molecular connection between sodium and glucose worked in vivo.
The view of the scientific establishment on the discovery and development of ORT overlooks the practical work in Dacca and Calcutta and reserves its ultimate praise for the IX IX7 Hirschhorn, interview, It) January 1992, transcript p. 1. Hirschhorn credits Nalin and Cash with having worked out the practical application for ORT. As to the question of who discovered ORT, Hirschhorn believes that it was "all a mosaic". most theoretical studies. This attitude was well represented by the Lancet when the editors declared that "The discovery that sodium transport and glucose transport are coupled in the small intestine, so that glucose accelerates absorption of solute and water, was potentially the most important medical advance this century'88 This judgement implies that the findings of Crane, Schultz and Curran were the direct predecessors of ORT-a conclusion that ignores crucial metabolic studies and Nalin's brilliant leap to a practical regimen.'89 The co-transport research was crucial primarily because the researchers who developed ORT could point to it for support. The statement in the Lancet reflects the temptation for historians and scientists to reduce scientific discoveries to a line of theoretical breakthroughs that appear to flow smoothly into practical applications. ORT is an example of the difficult path that may lead to a discovery-from Phillips' extraordinary observation to a simple solution any parent can administer to a sick child.
THE POTENTIAL FOR ORT BEFORE 1968
Given the extremely simple composition of ORT, one might expect that an examination of the medical literature would reveal previous, successful oral therapy experiments. Only one comes to light that not only was independent of many important physiological studies, but preceded them. In 1953, Hemendra Nath Chatterjee, an Indian doctor working on cholera in Calcutta, managed to rehydrate patients with "mild to moderately severe cholera ... without intravenous or parenteral transfusions" and published his findings in the Lancet.'90 He treated 186 patients with an oral glucose-sodium electrolyte solution that closely resembled the one employed by Nalin fifteen years later, and there were no fatalities. However, Chatterjee's work failed to provide controls and net fluid balance sheets, scientific tools that might have fostered credibility;'9' and his use of exotic Indian plants to halt vomiting and diarrhoea, as well as his administration of some rehydration therapy by enema may have struck the readership of the Lancet as being too foreign and unscientific. Whatever the case, his article failed to stimulate follow-up studies. It is generally agreed that racism or the lack of a "scientific" rationale prevented the widespread adoption of his work.'92 While Chatterjee's study did not present or cite a supportive physiological paradigm and could therefore be branded as a fluke, one might question whether a doctor could have extrapolated an effective oral therapy from early glucose-sodium co-transport studies. The experience of Qais Al-Awqati, an Iraqi physician, implies that this was in fact possible.
In 1966 a cholera epidemic erupted in Baghdad where Al-Awqati was doing his medical residency. Although he lacked scientific training and was unaware of the research in Calcutta and Dacca, Al-Awqati had studied the physiological experiments of Crane and, decided to try an oral electrolyte solution based on them. During the six weeks of the "'X 'Water with sugar and salt', editorial, Lancet, 1978, ii: 300.
189 Interestingly, Schultz contends that the discovery "was largely a matter of an idea whose time had come". By ORT might also have been developed long before 1968 but for the attitudes of the dominant medical establishment toward practical experimentation, which the Cholera Research Laboratory and the National Institutes for Health shared. Nalin believes that "the people at the lab ... got kudos for the extent to which [their] work was not practical. As soon as it became practical it was discarded like a soiled towel-it was too common, too hands-on... so the prestige went to people who measured trans-intestinal fluxes or electrical currents". 95 Phillips, who wanted nothing to do with practical applications, no doubt profoundly influenced Nalin's perspective. However, he was a talented researcher and a better rounded scientist than these incidents reveal. His methodology for experimentation was to test a brilliant idea on a very small scale; if the results were positive, he would then continue. This framework clashed with the desire of Nalin and 1"3 Qais Al-Awqati, interview, 19 February 1992, transcript p. 2. See also Qais S. Al-Awqati, Mehdi Mekkiya, and Mahmud Thamer, 'Establishment of a cholera treatment unit under epidemic conditions in a developing country', Lincet, 1969, i: 252. This article was written only after Al-Awqati arrived in the United States and was encouraged by Dr Greenough. The editors of the Lancet rewrote the article and hardly mentioned that the doctors had used oral therapy, concentrating instead on the public health perspective of the story.
"' Nalin discourages this notion and states that the paradigm that there is "a logical progression from basic science to applied science lisl a fiction lin this instancel". Nalin, interview, 14 February 1992, transcript p. 17.
1'5 Ibid., p. 15.
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Joshua Nalibow Ruxin Cash to conduct large scale practical experimentation. Nalin states accordingly that Phillips "was the essence of the creative scientist whereas he reported to Seal [and the NIH as] the essence of the Bethesda bureaucrat".'96
Although Phillips, the symbol of conservative medical approach in Dacca, influenced Nalin and Cash, they were sufficiently free from the dogma of the medical establishment to design and execute their own work. Hirschhorn and Pierce believe that one trait shared by nearly all the oral rehydration investigators was that, ironically, they had no training or experience in paediatric medicine.'97 They were working towards a therapy that would benefit children, but they had not been indoctrinated by the paediatric medical establishment which embraced intravenous therapy and opposed oral therapy.
ORT, even in the light of co-transport theory, had to break through conceptual barriers in order to gain acceptance. Most investigators could not imagine patients swallowing and holding down the amount of fluid required for an oral therapy regimen. Nalin and Cash shattered this mental block with the second protocol demonstrating that the contrary was true. Since this work convinced only themselves and their immediate peers, I believe that it is appropriate to refer to their experiment in Dacca formally as the "discovery" of oral therapy. Their initial work, however, did not account for the global implementation of ORT programmes. Without the crucial diffusion that Mahalanabis and others inspired, ORT would have remained a discovery of far less importance.'98
The amount of time needed for the U.S. medical establishment to accept ORT dwarfs the seven years that passed before the major public health institutions of the world embarked on a global ORT programme. In 1992 a small group of researchers met in Atlanta, Georgia, under the auspices of the Centers for Disease Control (CDC) to discuss a plan to benefit American children by promoting the therapy. The CDC had called the meeting in order to make a public statement on the value of ORT in the U.S. ' In contrast to the U.S., the developing world uses Oral Rehydration Therapy extensively. In addition to saving millions of lives there, its use should draw more attention to the poor water supplies and unsanitary living conditions that create such an immense need for the therapy. ORT is not a solution to the global epidemic of diarrhoea: it is only a treatment that prevents diarrhoeal deaths. ORT can buy time for nations and international development organizations to marshal their resources for clean water, sanitation, and other projects that constitute long-term solutions to diarrhoeal disease.
